Actuate Therapeutics, Inc. (ACTU)
NASDAQ: ACTU · Real-Time Price · USD
8.15
0.00 (0.00%)
Sep 6, 2024, 4:00 PM EDT - Market closed
Actuate Therapeutics Employees
Actuate Therapeutics had 5 employees as of December 31, 2023.
Employees
5
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
-$5,554,085
Market Cap
155.76M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 5 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| MultiPlan | 2,800 |
| 23andMe Holding Co. | 582 |
| Amylyx Pharmaceuticals | 384 |
| Caribou Biosciences | 158 |
| Alpha Tau Medical | 121 |
| Lineage Cell Therapeutics | 75 |
| Cybin | 50 |
| Galectin Therapeutics | 14 |
ACTU News
- 3 days ago - Actuate to Present at the H.C. Wainwright 26th Annual Global Investment Conference - GlobeNewsWire
- 22 days ago - U.S. IPO Weekly Recap: WeRide Reschedules While 6 New Filers Join The Pipeline - Seeking Alpha
- 24 days ago - Actuate Therapeutics Announces Closing of Initial Public Offering - GlobeNewsWire
- 26 days ago - Actuate Therapeutics Announces Pricing of Initial Public Offering - GlobeNewsWire
- 5 weeks ago - U.S. IPO Weekly Recap: August Kicks Off With One Small Pricing - Seeking Alpha
- 7 weeks ago - U.S. IPO Weekly Recap: Insurance And Healthcare Lead A 4 IPO Week - Seeking Alpha
- 3 months ago - Actuate Therapeutics Seeks IPO For Promising Pancreatic Cancer Drugs - Seeking Alpha
- 3 months ago - Actuate Therapeutics Files Registration Statement for Initial Public Offering - GLOBE NEWSWIRE